A · Agilent Technologies, Inc. · Executive Compensation
$173.07
-0.82 (-0.47%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$48.79B
Shares
281.93M
Volume · Oct 23
1.76M
Avg daily vol (3M)
2.21M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Glenn Boehnlein | Class III director | Appointed | 2026-09-08 |
| Boon Hwee Koh | Chairperson of the Board of Directors | Retired | 2026-09-08 |
| Bret DiMarco | Senior Vice President, Chief Legal Officer and Secretary | Resigned | 2026-05-04 |
| Michael Buckner | Chief Legal Officer | Appointed | 2026-05-04 |
| Adam S. Elinoff | Senior Vice President and Chief Financial Officer | Appointed | 2025-10-27 |
| Rodney Gonsalves | interim Chief Financial Officer and interim Principal Financial Officer | Appointed | 2025-07-15 |
| Robert W. McMahon | Senior Vice President, Chief Financial Officer | Resigned | 2025-07-15 |
| Judy Gawlik Brown | Board of Directors | Appointed | 2025-05-21 |
| Heidi Kunz | Board of Directors | Retired | 2025-05-21 |
| Pascal Soriot | Board of Directors | Appointed | 2025-05-21 |
| Judy Gawlik Brown | director | Appointed | 2025-05-21 |
| Pascal Soriot | director | Appointed | 2025-05-21 |
| Henrick Ancher-Jensen | Senior Vice President, Agilent President, Order Fulfillment and Supply Chain | Resigned | 2025-05-02 |
| Heidi Kunz | member of the Board of Directors | Resigned | 2025-04-02 |
| Padraig McDonnell | member of the Company's Board | Appointed | 2024-05-01 |
| Padraig McDonnell | CEO | Appointed | 2024-05-01 |
| Michael McMullen | member of the Company's Board | Retired | 2024-05-01 |
| Michael McMullen | President and Chief Executive Officer | Retired | 2024-05-01 |
| Padraig McDonnell | Chief Operating Officer (“COO”) and CEO-elect | Appointed | 2024-02-21 |
| Michael McMullen | member of the Company's Board of Directors | Retired | 2024-02-21 |
| Michael McMullen | President and Chief Executive Officer | Retired | 2024-02-21 |
| Sam Raha | Senior Vice President of the Company and President of the Diagnostics and Genomics Group ("DGG") | Resigned | 2023-11-01 |
| Philip Binns | president of the company’s Life Sciences and Applied Markets Group (LSAG) | Appointed | 2023-09-05 |
| Jacob Thaysen | Senior Vice President of the Company, and president, Life Sciences and Applied Markets Group (LSAG) | Resigned | 2023-09-05 |
Leadership
- Adam S. Elinoff CFO
- Rodney Gonsalves CFO
- Padraig McDonnell COO, Board Member
- Michael Buckner General Counsel
- Dow R. Wilson Board Member
- Dr. Mikael Dolsten Board Member
- George A. Scangos Board Member
- Glenn Boehnlein Board Member
- Judy Gawlik Brown Board Member
- Pascal Soriot Board Member
- Sue H. Rataj Board Member
Key facts
CIK
1090872
CUSIP
00846U101
13F (30d)
308 filings
296 filers
Visit website
Investor relations